Company / Inventory
Integra Lifesciences Holdings Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$492.7M
FY2025
5-year range
$317.4M / $492.7M
FY2021-FY2025
Trend
+14.8%
vs FY2024
Sector context
#41 of 115
Health Care
What the data says
At $493M, Integra Lifesciences Holdings's inventory ranks #41 of 115 in the Health Care sector. Inventory has increased for 5 consecutive years, from $310M in FY2020 to $493M in FY2025.
Based on SEC 10-K filings.
$493M in FY2025 with a 5-year CAGR of +9.7%.
Improved from $390M to $493M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Sector benchmark
#41 of 115 in Health CareTop 36% of 115This company $492.7M Sector average $1.4B
▼
-64.9% below sector average
Key checks
Key Insights
- Integra Lifesciences Holdings's inventory has grown for 5 consecutive years.
- 5-year CAGR of +9.7%, indicating consistent growth.
- In FY2025, inventory increased 14.8% year-over-year.
- Ranks #41 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $492.7M | +14.8% |
| FY2024 | $429.1M | +10.1% |
| FY2023 | $389.6M | +20.0% |
| FY2022 | $324.6M | +2.3% |
| FY2021 | $317.4M | +2.3% |
| FY2020 | $310.1M | -1.9% |
| FY2019 | $316.1M | +12.7% |
| FY2018 | $280.3M | -5.4% |
| FY2017 | $296.3M | +36.4% |
| FY2016 | $217.3M | +2.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026